Translational & Clinical Development Strategy

Sentikon works with organizations to align science, clinical design, and execution early, where decisions most strongly influence downstream risk and probability of success.

We focus on population strategy, endpoints, biomarkers, and evidence planning to support regulatory credibility, commercial viability, and investment confidence. Our work identifies and mitigates risk before it becomes embedded in development programs.

Representative areas of focus:

• Translational alignment from bench to bedside
• Clinical trial design and endpoint strategy
• Biomarker and evidence planning
• Program risk assessment and optimization